≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Malnutrition

DOID EFO Endpoint Browser PheWeb

E4_MALNUTRITION

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — E40-E46
  • Cause of death: ICD-10 — E40-E46

2 out of 7 registries used, show all original rules.

660

4. Check minimum number of events

None

660

5. Include endpoints

700

6. Filter based on genotype QC (FinnGen only)

700

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
2
First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 9178 5172 3965
Only index persons 7591 4380 3211
Unadjusted period prevalence (%)
Whole population 0.13 0.15 0.11
Only index persons 0.14 0.16 0.12
Median age at first event (years)
Whole population 67.39 70.70 63.06
Only index persons 68.88 71.80 64.89

-FinnGen-

Key figures

All Female Male
Number of individuals 700 386 314
Unadjusted period prevalence (%) 0.13 0.13 0.14
Median age at first event (years) 63.37 61.28 65.94

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
615
Matched controls
6149
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
E44.0
ICD-10 Finland
Moderate protein-energy malnutrition
+∞
173.3
158
*
E46
ICD-10 Finland
Unspecified protein-energy malnutrition
+∞
168.7
154
*
E44.1
ICD-10 Finland
Mild protein-energy malnutrition
1036.3
93.4
89
*
E42
ICD-10 Finland
Marasmic kwashiorkor
+∞
77.8
73
*
E43
ICD-10 Finland
Unspecified severe protein-energy malnutrition
+∞
51.8
49
*
E41
ICD-10 Finland
Nutritional marasmus
+∞
48.6
46
*
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
31.7
35.7
47
16
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.9
35.6
173
563
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
15.5
34.9
58
41
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
7.7
34.6
84
124
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.8
33.4
166
547
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.6
30.0
154
516
R63.4
ICD-10 Finland
Abnormal weight loss
8.0
29.1
68
94
E40
ICD-10 Finland
Kwashiorkor
+∞
27.3
26
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.8
26.9
235
1128
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.8
25.8
215
998
602
Kela drug reimbursment
Children's severe malnutrition
16.4
24.9
40
26
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.5
22.1
239
1259
ZXD05
NOMESCO Finland
Urgent procedure
2.4
21.9
243
1296
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.3
21.7
303
1814
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.9
21.6
94
269
E86
ICD-10 Finland
Volume depletion
7.4
21.5
52
76
E45
ICD-10 Finland
Retarded development following protein-energy malnutrition
+∞
20.9
20
*
R53
ICD-10 Finland
Malaise and fatigue
2.6
20.3
179
838
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.4
20.2
240
1312
A28
ICPC
Limited function/disability NOS
2.8
19.2
145
616
AA1AD
NOMESCO Finland
CT of head and brain
2.5
19.2
179
861
A03FA01
ATC
metoclopramide; systemic, rectal
2.7
19.1
153
675
E87.6
ICD-10 Finland
Hypokalaemia
6.5
19.1
50
82
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.9
19.0
135
551
N05AX08
ATC
risperidone; systemic
3.8
18.5
83
243
N02AA05
ATC
oxycodone; systemic
3.0
18.2
119
461
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.1
18.0
74
200
L28
ICPC
Limited function/disability (L)
2.8
18.0
133
557
TPH07
NOMESCO Finland
Cathetrisation of artery
3.2
18.0
104
370
N05AH03
ATC
olanzapine; systemic
5.2
17.5
55
113
R4190
NOMESCO Finland
Nutritional therapy
4.5
17.5
64
155
SPAT1262
SPAT
Handing over of treatment supplies
2.6
17.3
142
628
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.1
16.7
97
345
B03BA03
ATC
hydroxocobalamin; parenteral
4.1
15.9
64
170
TJD20
NOMESCO Finland
Change of gastrostomy tube
16.2
15.8
25
16
26899
ICD-8 Finland
Nutritional marasmus
+∞
15.7
15
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.5
15.4
136
625
R63.0
ICD-10 Finland
Anorexia
32.6
14.9
19
6
TPX10
NOMESCO Finland
Implantation of vascular injection port
6.8
14.8
37
57
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
3.3
14.8
77
253
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.5
14.7
71
221
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
9.2
14.6
30
34
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
4.2
14.4
56
144
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
4.5
14.4
51
120
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
4.9
14.3
47
102
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
6.3
14.3
38
64
JDB10
NOMESCO Finland
Percutaneous gastrostomy
8.3
14.2
31
39
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.9
14.0
91
346
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.0
13.9
87
325
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
6.7
13.9
35
55
N17.9
ICD-10 Finland
Acute renal failure, unspecified
5.0
13.2
42
88
N03AX09
ATC
lamotrigine; oral
4.8
13.2
44
97
Z2446
NOMESCO Finland
Social worker
3.0
13.1
78
280
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.4
13.1
123
582
R11
ICD-10 Finland
Nausea and vomiting
2.9
12.9
81
301
RD210
NOMESCO Finland
NA
5.5
12.6
37
71
D64.9
ICD-10 Finland
Anaemia, unspecified
2.7
12.5
93
384
EBA15
NOMESCO Finland
Extraction of large number of teeth
4.4
12.5
45
108
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.0
12.4
213
1301
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
3.7
12.4
54
154
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
3.8
12.2
52
146
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.8
12.1
51
142
SPAT1216
SPAT
Assessment of functional ability
2.3
12.1
121
589
SPAT1229
SPAT
Assessment of need for aid
2.9
12.0
76
283
R13
ICD-10 Finland
Dysphagia
3.4
12.0
58
181
ZXE10
NOMESCO Finland
More than one and less than three hours
1.9
12.0
242
1570
A06AD11
ATC
lactulose; oral
2.3
11.9
118
570
JAH00
NOMESCO Finland
Laparotomy
5.1
11.9
37
76
I95.1
ICD-10 Finland
Orthostatic hypotension
4.3
11.9
44
109
Z01.8
ICD-10 Finland
Other specified special examinations
2.1
11.8
145
775
S97
ICPC
Chronic ulcer skin
3.6
11.7
54
162
T08
ICPC
Weight loss
6.9
11.6
28
42
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
3.6
11.5
52
154
N05BA04
ATC
oxazepam; oral
2.1
11.4
160
900
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.4
11.4
107
501
F10.25
ICD-10 Finland
Alcohol dependence continuous use
9.9
11.3
22
23
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
4.2
11.2
42
105
SPAT1301
SPAT
No procedures
1.9
11.2
218
1388
ZY010
NOMESCO Finland
Hospital outpatient
3.6
11.1
50
147
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
4.6
11.1
38
87
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
3.2
11.1
58
192
F50.0
ICD-10 Finland
Anorexia nervosa
14.2
11.0
18
13
C03CA01
ATC
furosemide; systemic
1.9
11.0
207
1298
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
7.1
11.0
26
38
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.0
10.9
179
1068
A02BC02
ATC
pantoprazole; systemic
1.8
10.8
361
2735
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
7.8
10.8
24
32
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.9
10.7
65
238
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.0
10.6
146
812
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.7
10.4
72
286
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
6.2
10.4
27
45
K91.2
ICD-10 Finland
Postsurgical malabsorption, not elsewhere classified
33.1
10.4
13
*
F50.9
ICD-10 Finland
Eating disorder, unspecified
10.9
10.3
19
18
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
2.6
10.2
75
309
WX408
NOMESCO Finland
General anesthesy, balanced
1.9
10.2
177
1071
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.7
10.2
70
277
A09AA02
ATC
multienzymes (lipase, protease etc.)
6.6
10.1
25
39
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.9
10.1
62
228
SPAT1254
SPAT
Administration of medicine
2.1
10.0
120
629
SPAT1249
SPAT
Treatment-related counselling outside office
1.8
10.0
240
1621
G40.9
ICD-10 Finland
Epilepsy, unspecified
4.2
10.0
37
92
130
Kela drug reimbursment
Malignant tumour
2.7
10.0
67
262
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.6
10.0
75
312
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
3.2
9.9
51
168
L89
ICD-10 Finland
Decubitus ulcer and pressure area
6.0
9.8
26
45
SPAT1255
SPAT
Intravenous administration of medicine
3.1
9.7
54
185
I50.9
ICD-10 Finland
Heart failure, unspecified
2.2
9.6
109
558
R33
ICD-10 Finland
Retention of urine
2.8
9.6
63
242
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.6
9.6
73
306
N05AH04
ATC
quetiapine; oral
2.2
9.5
102
506
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.3
9.5
93
442
W19
ICD-10 Finland
Unspecified fall
2.5
9.5
78
341
S72.1
ICD-10 Finland
Pertrochanteric fracture
5.0
9.4
29
60
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
12.6
9.4
16
13
SPAT1310
SPAT
Counselling related to known health issue
1.8
9.4
204
1329
V03AG01
ATC
sodium cellulose phosphate; systemic
22.1
9.4
13
6
ZX120
NOMESCO Finland
Intravenous
2.5
9.3
74
317
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
7.5
9.3
21
29
Z51.5
ICD-10 Finland
Palliative care
3.1
9.3
50
170
S01.0
ICD-10 Finland
Open wound of scalp
2.8
9.3
59
224
UJF32
NOMESCO Finland
Coloscopy
1.9
9.2
162
984
K59.09
ICD-10 Finland
Constipation, unspecified
2.8
9.1
57
213
ZXE00
NOMESCO Finland
One hour or less
1.7
9.1
246
1713
R50.9
ICD-10 Finland
Fever, unspecified
2.1
9.1
109
569
JN3AD
NOMESCO Finland
Abdominal CT examination
2.9
9.1
56
207
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
3.0
9.1
52
184
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.1
9.0
103
527
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.2
9.0
46
151
SPAT1263
SPAT
Sampling
1.7
8.9
257
1819
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.8
8.9
59
228
JN4CD
NOMESCO Finland
Very extensive body CT
4.0
8.9
34
88
M81.9
ICD-10 Finland
Osteoporosis, unspecified
3.6
8.8
39
114
N06AX11
ATC
mirtazapine; oral
1.8
8.8
180
1147
JN4AD
NOMESCO Finland
Body CT examination
3.0
8.8
51
182
S42.2
ICD-10 Finland
Fracture of upper end of humerus
3.5
8.8
40
120
F29
ICD-10 Finland
Unspecified nonorganic psychosis
4.5
8.7
30
70
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
14.3
8.7
14
10
WX302
NOMESCO Finland
Thoracal epidural anesthesy
3.2
8.7
45
149
T36
ICD-10 Finland
Poisoning by systemic antibiotics
3.9
8.7
34
90
B81
ICPC
Anaemia vit B12/folate deficiency
3.6
8.6
37
106
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
3.4
8.6
41
128
GD1AD
NOMESCO Finland
Thorax CT examination
4.8
8.5
27
58
P15
ICPC
Chronic alcohol abuse
5.8
8.5
23
41
H02AB09
ATC
hydrocortisone; systemic
3.9
8.5
34
92
N06AB10
ATC
escitalopram; oral
2.0
8.5
109
587
ZXE20
NOMESCO Finland
More than three and less than five hours
2.1
8.5
95
483
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
5.2
8.4
25
50
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.9
8.4
50
182
S72.0
ICD-10 Finland
Fracture of neck of femur
3.4
8.4
39
119
NFJ54
NOMESCO Finland
Internal fixation of fracture of upper femur with intramedullary nail
6.4
8.4
21
34
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
9.6
8.3
16
17
N03AG01
ATC
valproic acid; systemic, rectal
3.0
8.3
47
164
A04
ICPC
Weakness/tiredness general
2.1
8.3
96
495
R60.0
ICD-10 Finland
Localized oedema
2.3
8.2
80
378
R63.8
ICD-10 Finland
Other symptoms and signs concerning food and fluid intake
14.7
8.2
13
9
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
2.4
8.2
70
310
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
7.7
8.2
18
24
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
4.2
8.1
29
71
N04AA02
ATC
biperiden; systemic
6.0
8.0
21
36
L04AX01
ATC
azathioprine; systemic
3.4
8.0
38
118
K23.8*B37.8
ICD-10 Finland
Esophagitis caused by candidiasis
22.4
8.0
11
5
Z98.8
ICD-10 Finland
Other specified postsurgical states
7.4
8.0
18
25
JN4BD
NOMESCO Finland
Extensive body CT
2.3
7.9
71
324
H03AA01
ATC
levothyroxine sodium; systemic
1.9
7.9
139
838
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.6
7.8
54
216
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
3.3
7.8
38
121
N06AB04
ATC
citalopram; systemic
1.9
7.8
123
713
SPAT1281
SPAT
Other administrative function
2.5
7.7
59
248
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.7
7.7
241
1726
T91
ICPC
Vitamin/nutritional deficiency
12.0
7.6
13
11
F50.1
ICD-10 Finland
Atypical anorexia nervosa
12.0
7.6
13
11
N05CF01
ATC
zopiclone; oral
1.7
7.6
190
1277
JDD00
NOMESCO Finland
Total gastrectomy and Roux-en-Y oesophagojejunostomy
25.4
7.6
10
*
C03DA01
ATC
spironolactone; oral
2.2
7.5
78
382
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
4.5
7.5
25
57
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.1
7.5
90
468
SPAT1312
SPAT
General health counselling
1.7
7.5
210
1457
TQW11
NOMESCO Finland
Vacuum treatment of wound
6.6
7.5
18
28
SPAT1260
SPAT
Consultation of another employee
1.9
7.4
107
601
E83.4
ICD-10 Finland
Disorders of magnesium metabolism
81.0
7.4
8
*
SPAT1240
SPAT
Therapeutic discussion
2.3
7.4
66
303
F03
ICD-10 Finland
Unspecified dementia
3.0
7.4
42
148
SPAT1245
SPAT
Provision of support and information to patient’s family members
3.1
7.2
38
129
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
4.0
7.2
27
70
M81.8
ICD-10 Finland
Other osteoporosis
8.1
7.1
15
19
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.9
7.1
41
146
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
5.7
7.1
19
34
127
Kela drug reimbursment
Transplant complication
5.7
7.1
19
34
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
3.4
7.1
33
102
R41.0
ICD-10 Finland
Disorientation, unspecified
3.3
7.0
33
103
J01MA02
ATC
ciprofloxacin; systemic
1.6
6.9
214
1520
SPAT1153
SPAT
Removal of sutures
1.7
6.9
176
1187
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.7
6.9
46
181
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.8
6.9
41
151
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
5.1
6.8
20
40
N06AX21
ATC
duloxetine; oral
2.3
6.8
62
286
G72.8
ICD-10 Finland
Other specified myopathies
6.8
6.8
16
24
N06AX16
ATC
venlafaxine; oral
2.2
6.8
71
349
F60.9
ICD-10 Finland
Personality disorder, unspecified
9.5
6.8
13
14
A04AA01
ATC
ondansetron; systemic, rectal
2.7
6.8
45
177
NE1AA
NOMESCO Finland
Pelvis X-ray examination
2.5
6.8
53
226
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.2
6.7
68
329
K90.3
ICD-10 Finland
Pancreatic steatorrhoea
22.8
6.7
9
*
Z93.1
ICD-10 Finland
Gastrostomy status
22.8
6.7
9
*
SPAT1125
SPAT
Stoma care and guidance
5.3
6.7
19
37
F10.20
ICD-10 Finland
Alcohol dependence currently independent
6.5
6.7
16
25
N91.1
ICD-10 Finland
Secondary amenorrhoea
6.0
6.6
17
29
A07AA02
ATC
nystatin; oral
2.7
6.6
43
166
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.1
6.6
78
405
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.1
6.6
76
391
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.4
6.6
53
232
N05CD07
ATC
temazepam; oral
2.1
6.6
76
392
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
3.4
6.5
29
87
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.8
6.5
129
808
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.3
6.5
57
260
JDB01
NOMESCO Finland
Laparoscopic gastrostomy
70.5
6.4
7
*
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
5.0
6.4
19
39
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.9
6.4
37
133
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
6.7
6.4
15
23
ZY000
NOMESCO Finland
Hospital inpatient
6.7
6.4
15
23
ZYB02
NOMESCO Finland
Outreach service at unit of another specialty
8.3
6.4
13
16
K08.3
ICD-10 Finland
Retained dental root
2.6
6.3
44
175
183
Kela drug reimbursment
Lamotrigin and topiramate
6.1
6.3
16
27
U04
ICPC
Incontinence urine
2.9
6.3
36
127
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
11.2
6.3
11
10
R4180
NOMESCO Finland
Podiatric therapy
9.4
6.3
12
13
A02BC05
ATC
esomeprazole; systemic
1.6
6.3
209
1503
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.9
6.3
37
135
WX882
NOMESCO Finland
High dependency care
2.9
6.3
36
128
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
3.5
6.3
27
79
Z2445
NOMESCO Finland
Psychologist
2.7
6.3
40
152
C09.9
ICD-10 Finland
Malignant neoplasm: Tonsil, unspecified
+∞
6.3
6
*
E83.39
ICD-10 Finland
Other disorder of phosphorus metabolism
+∞
6.3
6
*
M03BX01
ATC
baclofen; systemic
7.1
6.2
14
20
R64
ICD-10 Finland
Cachexia
27.0
6.2
8
*
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.4
6.2
48
206
TPH04
NOMESCO Finland
Cathetrisation of vein
1.7
6.2
126
790
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
5.8
6.2
16
28
ZXA00
NOMESCO Finland
Right side
1.7
6.2
159
1068
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
3.4
6.2
28
86
N05AA02
ATC
levomepromazine; systemic
3.4
6.2
28
86
L04AD01
ATC
ciclosporin; systemic
4.7
6.1
19
41
K59.1
ICD-10 Finland
Functional diarrhoea
2.8
6.1
37
138
Z49.1
ICD-10 Finland
Extracorporeal dialysis
8.7
6.1
12
14
F10.24
ICD-10 Finland
Alcohol depence active use
10.2
6.0
11
11
NFB20
NOMESCO Finland
Primary partial prosthetic replacement of hip joint using cement, other or unspecified
3.7
6.0
24
66

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
249
549
6.49
115.18
3.5
2.9
g/l
0.2
0.2
7.75
234
516
(3012095) Magnesium [Moles/volume] in Serum or Plasma
295
886
5.03
93.44
8.2
5.3
mmol/l
0.8
0.8
3.24
279
829
(3003458) Phosphate [Moles/volume] in Serum or Plasma
286
847
5.02
91.97
10.5
7.4
mmol/l
1.1
1.1
0.09
272
772
(3024561) Albumin [Mass/volume] in Serum or Plasma
475
2330
4.23
72.35
8.7
5.5
g/l
31.9
35.5
24.36
460
2160
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
341
1521
3.42
55.87
3.1
2.5
mg/l
3.4
3.0
1.14
313
1289
(3022948) Iron [Moles/volume] in Serum or Plasma
245
911
3.60
53.27
3.1
2.6
umol/l
10.6
12.8
2.11
232
837
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
495
2869
3.48
50.66
13.7
7.8
mmol/l
1.2
1.2
5.01
397
2447
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
220
787
3.62
50.42
3.3
2.7
%
19.9
22.0
0.83
190
674
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
467
2635
3.32
49.56
13.3
7.5
mmol/l
1.2
1.2
6.52
444
2387
(3004789) Transferrin [Mass/volume] in Serum or Plasma
226
834
3.53
49.21
3.1
2.6
g/l
2.2
2.4
2.72
218
769
(3019309) Folate [Moles/volume] in Red Blood Cells
262
1071
3.31
48.20
2.7
1.8
nmol/l
1548.5
1178.7
6.28
201
791
(3023368) Bacteria identified in Blood by Culture
324
1520
3.11
46.78
5.9
4.2
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
337
1632
3.05
45.73
3.8
2.6
u/l
55.8
58.0
0.45
314
1505
(3036481) Cortisol [Moles/volume] in Serum or Plasma
173
565
3.74
45.00
2.2
2.1
nmol/l
393.8
368.6
0.66
164
515
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
416
2284
3.02
44.58
4.2
2.6
nmol/l
73.0
76.7
1.72
399
2037
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
42
38
11.69
40.11
3.7
3.2
umol/l
25.6
29.0
0.52
42
38
(3027945) Reticulocytes/100 erythrocytes in Blood
195
735
3.29
40.08
3.6
3.5
%
1.8
1.7
0.59
173
661
(3015377) Calcium [Moles/volume] in Serum or Plasma
354
1865
2.82
39.54
3.8
3.2
mmol/l
2.3
2.4
4.67
321
1622
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
454
2763
2.83
37.60
9.2
6.2
umol/l
12.7
12.9
0.08
434
2605
(3023520) Reticulocytes [#/volume] in Blood
154
534
3.42
35.90
3.6
3.0
e9/l
68.1
68.3
0.02
128
417
(1616796) Gas panel - Central venous blood
66
122
5.87
34.77
4.8
4.0
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
380
2180
2.63
34.31
13.9
9.3
inr
1.2
1.3
0.33
152
618
(3001122) Ferritin [Mass/volume] in Serum or Plasma
405
2407
2.62
33.81
4.0
2.9
ug/l
210.1
114.9
0.98
373
2203
(3018418) pH of Serum or Plasma
315
1663
2.63
33.61
6.6
3.9
ph
7.4
7.4
0.10
106
302
(3012501) Base excess in Blood by calculation
64
121
5.72
32.90
5.2
4.0
mmol/l
3.5
2.6
1.03
44
82
(3013826) Glucose [Moles/volume] in Serum or Plasma
491
3238
2.73
32.54
10.3
5.5
mmol/l
6.6
6.6
0.00
479
3013
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
374
2177
2.54
32.06
2.6
2.0
pmol/l
86.6
94.6
2.63
226
1097
(3026782) Osmolality of Urine
247
1183
2.68
31.80
4.5
3.2
mosm/kgh2o
506.5
550.7
2.90
223
1005
(3021960) Folate [Moles/volume] in Serum or Plasma
262
1316
2.58
30.35
2.0
1.5
nmol/l
21.4
21.0
0.13
233
1113
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
122
406
3.43
30.03
2.1
1.7
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
129
446
3.32
29.86
7.2
4.0
mmol/l
1.2
1.2
2.15
119
386
(3007853) Bacteria identified in Skin by Aerobe culture
170
690
2.93
29.84
2.7
1.8
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
237
1154
2.59
29.07
6.9
4.9
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
183
790
2.78
28.49
2.8
2.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
272
1428
2.48
28.28
6.3
4.3
estimate
0.0
0.0
0.00
112
482
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
232
1133
2.57
28.14
2.1
1.7
pmol/l
458.7
7228064.2
0.50
181
927
(3017181) Myelocytes/100 leukocytes in Blood
123
432
3.24
27.63
4.3
4.7
%
1.1
0.9
0.34
51
142
(3026008) Bacteria identified in Urine by Culture
316
1795
2.39
27.34
4.6
3.4
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
117
402
3.29
27.23
4.4
4.8
%
0.1
0.2
0.11
46
126
(40767503) Oxygen content in Capillary blood by calculation
57
116
5.26
26.97
3.6
2.6
%
15.9
15.9
0.01
27
62
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
347
2062
2.35
26.94
5.3
3.8
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
143
573
2.88
25.37
7.1
3.5
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
58
127
4.89
25.21
3.0
3.4
umol/l
32.6
37.8
0.75
49
106
(42870588) Differential panel, method unspecified - Blood
330
1960
2.29
25.16
9.9
6.7
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
286
1603
2.33
24.98
3.4
2.1
u/l
188.7
263.5
0.81
265
1512
(3005719) IgG [Mass/volume] in Serum or Plasma
118
428
3.11
24.98
3.6
3.1
g/l
10.1
9.9
0.14
105
393
(3006315) Basophils [#/volume] in Blood
427
2835
2.30
24.72
9.7
6.4
e9/l
0.0
0.0
1.48
393
2437
(3015235) Bicarbonate [Moles/volume] in Capillary blood
71
186
4.14
24.62
8.1
6.7
mmol/l
24.2
24.2
0.02
66
160
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
65
162
4.32
24.06
2.3
1.9
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
424
2828
2.27
23.98
9.8
6.4
e9/l
0.6
0.6
0.75
391
2425
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
148
621
2.75
23.97
3.9
4.4
u/l
277.9
246.5
1.39
134
585
(3013115) Eosinophils [#/volume] in Blood
434
2924
2.27
23.93
10.4
6.7
e9/l
0.2
0.2
0.85
403
2553
(3003181) Sodium [Moles/volume] in Urine
52
109
5.07
23.76
1.6
1.7
mmol/l
64.8
65.9
0.06
41
93
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
71
191
4.02
23.73
1.7
1.4
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
77
221
3.79
23.50
2.4
2.1
ug/l
3.2
3.4
0.02
70
185
(3019198) Lymphocytes [#/volume] in Blood
431
2909
2.25
23.47
9.8
6.4
e9/l
1.8
2.0
0.84
399
2550
(3014111) Lactate [Moles/volume] in Serum or Plasma
132
527
2.85
23.46
10.3
8.0
mmol/l
1.4
1.4
0.07
116
490
(3025159) Blasts/100 leukocytes in Blood
107
383
3.12
23.09
4.7
4.9
%
0.0
0.9
0.55
37
105
(3002582) Erythrocytes [#/volume] in Urine
302
1780
2.23
22.89
5.2
3.9
e6/l
214.2
99.2
0.40
268
1389
(40761536) Microorganisms panel - Urine sediment
119
455
2.95
22.86
6.4
4.1
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
543
4063
2.50
22.85
11.9
7.2
u/l
104.1
85.1
5.33
527
3790
(3000570) Elastase.pancreatic [Mass/mass] in Stool
63
160
4.23
22.74
1.4
1.5
ug/g
271.0
294.7
0.32
38
102
(3002179) Metamyelocytes/100 leukocytes in Blood
106
382
3.09
22.59
4.5
4.5
%
0.6
0.6
0.00
33
96
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
122
480
2.87
22.21
5.0
5.2
ng/l
86.6
77.3
0.43
104
431
(40760888) Immunoglobulin light chains.free panel - Serum
52
116
4.76
22.08
1.9
4.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
157
706
2.58
21.98
1.5
1.3
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
63
165
4.10
21.81
2.6
1.8
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
230
1232
2.29
21.79
4.1
3.0
e6/l
5.7
6.3
0.30
209
1081
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
75
223
3.65
21.71
14.6
14.1
mg/l
1.4
1.4
0.13
69
209
(3035350) Ketones [Presence] in Urine by Test strip
397
2643
2.16
21.70
5.8
4.1
estimate
0.0
0.0
0.00
122
492
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
38
65
6.12
21.56
2.2
1.9
pg
32.8
32.6
0.09
38
65
(3020630) Protein [Mass/volume] in Serum or Plasma
116
451
2.88
21.55
2.3
3.1
g/l
62.4
65.8
2.51
108
403
(3013650) Neutrophils [#/volume] in Blood by Automated count
461
3259
2.21
21.53
14.1
9.3
e9/l
4.4
4.0
2.81
425
2825
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
52
119
4.64
21.40
9.4
9.5
iu/ml
378.8
344.4
—
8
21
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
187
925
2.39
21.23
2.6
1.9
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
153
690
2.56
21.23
10.2
6.2
kpa
6.0
5.8
1.43
144
664
(3002032) Base excess in Venous blood by calculation
152
685
2.56
21.11
10.3
6.2
mmol/l
1.9
1.7
0.18
122
530
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
79
248
3.46
21.05
1.5
1.8
g/l
1.4
1.4
0.29
66
219
(3019069) Monocytes/100 leukocytes in Blood
402
2714
2.13
20.88
10.3
6.8
%
8.7
8.6
0.15
385
2560
(3021601) Nitrite [Presence] in Urine by Test strip
395
2651
2.12
20.82
7.4
5.7
estimate
0.0
0.0
0.00
124
491
(3018095) Leukocytes [#/volume] in Urine
329
2061
2.13
20.80
6.6
4.5
e6/l
175.7
101.3
0.85
277
1482
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
326
2037
2.12
20.73
5.9
4.0
ng/l
55.4
54.7
0.01
266
1446
(3009261) Glucose [Presence] in Urine by Test strip
397
2674
2.12
20.67
6.0
4.1
estimate
0.0
0.0
0.00
120
480
(3006504) Eosinophils/100 leukocytes in Blood
399
2694
2.12
20.62
10.1
6.5
%
2.4
2.9
3.73
382
2523
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
48
106
4.79
20.62
2.2
1.7
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
324
2024
2.12
20.58
6.4
4.3
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
68
197
3.72
20.43
3.2
2.3
ug/l
575.2
289.6
1.09
59
183
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
129
548
2.66
20.15
12.8
7.3
mmol/l
1.5
1.6
0.10
98
387
(3009343) pH of Capillary blood
132
568
2.63
20.09
12.8
7.2
ph
7.4
7.4
0.92
24
45
(3022096) Basophils/100 leukocytes in Blood
390
2629
2.09
20.02
10.1
6.6
%
0.6
0.7
1.82
374
2467
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
51
123
4.39
19.65
1.8
1.7
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
132
575
2.60
19.56
12.9
7.1
kpa
5.2
5.1
0.31
125
536
(3031040) Bacteria [#/volume] in Urine by Automated count
492
3653
2.17
19.12
7.8
5.0
e6/l
474.1
2569.7
1.16
14
64
(3002030) Lymphocytes/100 leukocytes in Blood
404
2794
2.05
18.93
10.2
6.6
%
25.3
29.2
7.38
385
2621
(3041096) Erythrocytes [Presence] in Urine by Automated
248
1444
2.11
18.52
5.8
3.8
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
79
269
3.18
18.42
5.1
4.2
mmol/l
25.2
25.1
0.03
71
262
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
365
2457
2.01
18.18
5.7
4.3
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
57
159
3.81
18.06
1.9
1.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
89
329
2.95
18.00
1.7
1.5
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
95
365
2.85
17.91
2.0
2.5
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
41
90
4.78
17.73
1.8
1.8
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
279
1719
2.04
17.71
3.8
2.6
—
—
—
0
0
(3019060) Gas panel - Arterial blood
94
364
2.83
17.45
6.1
5.6
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
55
155
3.77
17.17
2.1
3.8
ratio
1.3
2.1
—
8
18
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
29
48
6.26
16.97
1.5
1.7
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
133
619
2.42
16.96
10.2
5.9
kpa
4.8
4.8
0.16
126
592
(3034860) Kappa light chains.free [Mass/volume] in Serum
55
157
3.72
16.85
2.1
3.8
mg/l
54.2
96.7
0.50
35
125
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
55
157
3.72
16.85
2.1
3.8
mg/l
47.3
31.8
0.91
35
126
(3006653) Thiamine [Moles/volume] in Blood
21
24
8.99
16.85
1.7
1.1
nmol/l
116.3
144.1
0.90
21
24
(3003396) Base excess in Arterial blood by calculation
133
622
2.41
16.77
10.1
8.1
mmol/l
2.1
1.3
0.97
96
487
(3018010) Neutrophils/100 leukocytes in Blood
391
2747
1.96
16.68
9.9
6.4
%
58.6
55.7
3.50
371
2585
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
271
1681
2.00
16.64
4.4
3.5
u/l
53.3
33.7
0.62
255
1606
(3018677) aPTT in Platelet poor plasma by Coagulation assay
172
905
2.19
16.39
4.6
3.1
s
31.6
29.9
1.99
165
880
(3028026) IgM [Mass/volume] in Serum or Plasma
90
353
2.78
16.28
2.2
1.8
g/l
1.9
1.5
0.27
80
322
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
132
624
2.37
16.21
10.2
8.0
kpa
5.2
5.1
0.59
125
595
(3027801) Oxygen [Partial pressure] in Arterial blood
132
625
2.37
16.15
10.2
8.0
kpa
11.9
12.4
0.57
126
595
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
186
1021
2.12
15.84
3.9
2.9
mmol/l
2.5
2.5
0.33
168
886
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
119
544
2.43
15.72
2.3
1.6
%
2.0
1.5
3.09
102
482
(3016502) Oxygen saturation in Arterial blood
121
559
2.41
15.61
10.9
8.4
%
93.8
95.4
0.81
115
538
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
40
97
4.31
15.30
4.2
3.6
%
58.6
56.7
0.30
40
97
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
41
102
4.21
15.17
2.0
1.7
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
86
342
2.73
15.12
8.9
8.0
mmol/l
24.3
24.4
0.10
80
321
(3025941) Bacteria identified in Stool by Culture
78
296
2.84
14.98
1.6
1.3
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
55
173
3.37
14.55
3.1
2.6
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
506
3979
1.98
14.41
5.8
4.3
mm/h
16.6
12.3
5.52
472
3648
(3030905) Polymorphonuclear cells [#/volume] in Blood
38
94
4.22
14.17
3.4
3.2
e9/l
4.1
4.1
0.00
38
94
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
259
1652
1.90
14.14
5.2
3.5
ng/l
2296.7
1564.5
1.67
231
1407
(36304419) Bacteria [Presence] in Urine
249
1574
1.90
13.93
4.8
3.7
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
39
100
4.07
13.87
11.9
7.9
u/ml
369.9
2535.9
—
10
11
(3004119) Hemoglobin [Mass/volume] in Venous blood
84
345
2.63
13.84
8.6
5.5
g/l
121.2
126.7
1.41
77
337
(3020891) Body temperature
61
212
3.06
13.69
6.8
4.8
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
253
1625
1.87
13.36
4.9
3.8
e6/l
0.6
0.5
0.26
222
1236
(3021901) Oxygen saturation in Capillary blood
43
122
3.69
13.29
3.8
4.8
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
482
3777
1.89
13.26
6.7
4.6
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
32
73
4.55
13.21
1.9
1.8
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
514
4120
1.93
13.09
5.2
3.9
pmol/l
15.1
14.8
1.14
476
3685
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
430
3266
1.82
12.93
5.5
3.4
u/l
81.3
47.0
3.34
399
3034
(3007164) IgA [Mass/volume] in Serum or Plasma
207
1267
1.90
12.56
1.8
1.5
g/l
2.4
2.2
0.79
139
700
(3000991) Gas panel - Venous blood
119
599
2.19
12.40
14.9
9.0
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
219
1372
1.87
12.32
1.5
1.4
u/ml
0.9
1.4
1.41
69
307
(3013512) EKG study
235
1509
1.84
12.20
6.0
4.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
33
83
4.12
12.04
2.0
1.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
128
671
2.11
12.00
2.3
1.9
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
13
12
11.02
11.99
1.2
1.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
32
79
4.20
11.97
1.9
1.6
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
349
2542
1.74
11.64
22.4
10.2
e9/l
0.0
0.0
0.48
309
2060
(3028626) Oxygen [Partial pressure] in Capillary blood
80
349
2.46
11.59
13.9
8.5
kpa
9.4
9.2
0.38
72
325
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
127
673
2.08
11.55
2.5
1.9
—
—
—
0
0
(3000012) Reticulocyte production index
21
37
5.82
11.53
1.5
2.0
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
102
498
2.23
11.42
11.4
8.6
g/l
116.3
120.7
1.24
96
481
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
37
106
3.63
11.28
1.4
1.6
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
126
683
2.03
10.73
1.4
1.4
titre
360.0
549.4
0.96
21
143
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
46
158
3.05
10.54
1.7
1.8
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
33
92
3.71
10.47
6.4
3.5
—
—
—
0
0
(3022313) Gas panel - Capillary blood
93
454
2.21
10.39
12.2
7.2
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
53
199
2.80
10.37
5.5
4.8
g/l
3.3
3.4
0.10
48
191
(4035726)
91
449
2.18
9.89
1.8
1.5
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
70
309
2.41
9.87
4.9
3.3
e6/l
0.2
0.2
0.22
70
301
(3035637) Corticotropin [Mass/volume] in Plasma
33
97
3.52
9.71
1.5
1.6
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
17
29
5.98
9.63
1.5
1.7
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
14
20
7.12
9.31
1.2
1.3
nmol/l
66.1
103.2
—
9
14
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
28
76
3.80
9.24
1.5
1.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
22
50
4.51
9.14
1.7
1.5
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
25
63
4.08
9.12
3.6
3.2
mu/l
14.0
26.6
0.46
25
58
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
63
275
2.42
9.11
8.8
4.6
%
0.7
0.7
0.04
63
267
(3037756) Immunofixation for Serum or Plasma
35
113
3.21
8.91
1.2
1.6
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
29
83
3.60
8.88
3.8
3.8
u/ml
86.0
444.7
0.65
24
78
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
16
28
5.82
8.83
1.5
1.8
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
35
114
3.18
8.79
2.0
2.4
e6/l
6013.7
1132.2
0.45
29
93
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
35
114
3.18
8.79
2.0
2.3
e6/l
111.9
5.8
0.48
28
91
(40761535) Cells panel - Urine sediment
84
421
2.13
8.76
5.1
3.7
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
17
32
5.42
8.72
4.9
5.0
mg/l
74.9
96.8
0.41
12
27
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
88
452
2.08
8.60
13.4
6.8
mmol/l
23.5
23.9
0.58
81
422
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
22
53
4.25
8.51
3.5
3.0
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
66
306
2.28
8.33
4.0
3.0
pmol/l
4.2
4.7
1.94
58
261
(3019550) Sodium [Moles/volume] in Serum or Plasma
612
5452
1.97
8.27
40.0
18.0
mmol/l
138.4
139.6
15.16
604
5301
(3019150) Specific gravity of Urine by Refractometry
184
1212
1.70
8.24
5.7
4.3
kg/l
1.0
1.0
0.07
20
198
(3026250) Tacrolimus [Mass/volume] in Blood
18
38
4.84
8.15
56.6
38.9
ug/l
6.6
6.7
0.08
18
32
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
114
655
1.88
8.08
5.5
3.5
umol/l
13.5
7.7
1.03
95
564
(3023103) Potassium [Moles/volume] in Serum or Plasma
612
5462
1.96
8.08
40.1
18.1
mmol/l
4.0
4.0
1.15
604
5297
(3022217) INR in Platelet poor plasma by Coagulation assay
123
725
1.85
8.05
36.4
25.9
inr
1.4
1.3
0.30
16
87
(3000494) Fungus identified in Specimen by Culture
106
596
1.92
8.02
1.8
1.4
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
11
14
7.97
8.01
1.7
1.6
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
24
65
3.79
7.96
3.2
2.7
e9/l
1.4
1.1
0.38
17
36
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
561
4884
1.75
7.94
6.2
4.7
mu/l
2.0
2.2
0.35
529
4418
(44790047)
29
90
3.32
7.88
3.0
1.9
—
—
—
0
0
(44790048)
29
90
3.32
7.88
3.0
1.9
—
—
—
0
0
(44806118)
29
90
3.32
7.88
3.0
1.9
—
—
—
0
0
(44790049)
29
90
3.32
7.88
3.0
1.9
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
13
21
6.29
7.73
6.2
11.7
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
36
129
2.89
7.70
1.9
1.3
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
21
53
4.05
7.66
3.3
3.0
%
14.3
10.4
0.22
13
38
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
28
87
3.31
7.60
2.4
1.5
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
37
137
2.80
7.46
2.4
1.8
u/ml
97.5
106.2
0.25
11
19
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
76
390
2.06
7.44
3.5
2.9
ml/min/173m2
59.5
64.4
0.38
31
169
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
28
89
3.24
7.33
1.1
1.6
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
25
74
3.47
7.31
2.2
2.9
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
42
168
2.60
7.31
2.3
1.9
u/l
7.1
8.7
0.35
35
124
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
12
19
6.41
7.26
4.7
5.5
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
39
151
2.68
7.23
2.7
1.8
u/ml
233.8
238.6
0.02
21
77
(3003434) Protein [Mass/volume] in Pleural fluid
25
75
3.42
7.16
1.6
1.4
g/l
22.3
32.1
2.61
25
67
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
50
220
2.37
7.12
7.3
7.1
%
1.5
1.6
0.07
44
205
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
13
23
5.74
7.08
1.8
1.3
%
53.5
62.5
—
8
15
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
39
153
2.64
7.06
2.6
1.8
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
44
184
2.48
7.00
3.3
2.3
u/l
10402.6
3443.9
0.29
14
65
(3037121) Protein [Mass/volume] in Urine
52
235
2.31
6.98
3.9
5.3
g/l
0.5
0.4
0.14
29
107
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
37
143
2.68
6.90
2.3
1.8
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
43
180
2.48
6.83
11.4
6.4
u/ml
0.3
0.3
0.43
28
102
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
13
24
5.50
6.79
1.2
2.1
umol/l
173.4
69.5
—
8
15
(3044290) Cell count panel - Cerebral spinal fluid
29
99
3.01
6.77
2.4
2.5
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
25
78
3.29
6.75
5.0
4.2
umol/l
391.1
379.6
0.12
20
70
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
24
73
3.37
6.74
2.6
1.6
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
168
1133
1.64
6.72
2.9
2.2
mg/l
1.6
1.3
1.00
136
867
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
37
145
2.64
6.72
2.4
1.8
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
16
37
4.40
6.52
1.5
1.6
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
42
180
2.42
6.36
4.5
4.4
%
200.6
181.1
0.65
42
175
(3017143) Hepatitis C virus Ab [Presence] in Serum
100
600
1.78
6.12
1.7
1.5
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
47
217
2.25
6.02
7.4
7.2
%
0.8
0.9
1.82
42
201
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
14
31
4.59
6.00
1.1
1.3
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
186
1317
1.56
5.99
4.0
2.5
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
21
65
3.30
5.76
1.2
1.2
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
19
55
3.52
5.76
3.3
2.7
e6/l
826.1
465.7
0.98
12
40
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
599
5445
1.69
5.65
34.8
15.1
mg/l
27.7
24.5
1.59
540
4269
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
15
37
4.12
5.65
1.1
1.1
mg/l
44.9
31.2
—
10
30
(4027681)
13
29
4.55
5.53
1.3
1.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
112
719
1.66
5.36
2.8
2.6
ug/g
178.1
112.9
1.07
92
571
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
10
18
5.62
5.33
2.7
5.6
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
22
74
3.04
5.30
1.1
1.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
16
44
3.70
5.23
3.1
3.1
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
30
121
2.55
5.19
2.9
3.4
nmol/l
0.9
0.9
0.05
16
97
(3003694) ABO and Rh group [Type] in Blood
196
1444
1.50
5.15
1.7
1.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
97
606
1.70
5.14
15.6
7.9
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
188
1377
1.50
5.08
9.5
4.5
%
82.7
88.7
2.30
181
1351
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
606
5567
1.66
4.98
17.0
10.4
u/l
25.8
24.9
0.31
593
5346
(3044889) 12 lead EKG panel
414
3525
1.43
4.95
5.2
3.9
—
—
—
0
0
(40758558) Short blood count panel - Blood
201
1499
1.48
4.95
10.5
7.3
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
16
46
3.54
4.92
2.4
1.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
136
939
1.56
4.81
1.8
1.9
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
20
68
3.00
4.75
1.5
1.6
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
17
53
3.26
4.64
2.7
2.1
—
—
—
0
0
(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool
9
11
8.27
4.57
1.4
2.9
ug/g
228.4
106.5
—
9
11
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
138
967
1.53
4.55
4.8
3.5
e6/l
5.3
2.5
1.84
99
567
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
17
54
3.20
4.51
3.5
2.7
e9/l
0.2
0.2
0.39
12
40
(3000060) B lymphocytes [#/volume] in Blood
14
39
3.64
4.50
4.4
3.4
e6/l
272.2
237.0
—
9
20
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
42
210
2.06
4.46
2.9
1.9
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
602
5555
1.60
4.45
33.8
14.0
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
40
197
2.09
4.42
2.7
1.7
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
114
775
1.56
4.30
1.8
1.6
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
12
31
3.92
4.27
1.1
1.3
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
16
51
3.19
4.23
1.1
1.5
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
513
4599
1.43
4.21
38.6
18.8
%
14.3
13.7
13.37
504
4523
(3024928) Oxygen saturation in Venous blood
29
129
2.30
4.11
13.6
7.2
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
10
23
4.40
4.10
4.0
6.2
%
61.1
47.8
—
10
23
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
147
1067
1.48
4.07
5.1
4.0
ng/l
285.2
337.4
0.18
114
856
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
84
540
1.63
4.00
3.5
3.7
ug/l
5.6
30.1
0.99
74
450
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
14
43
3.30
3.92
1.4
1.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
17
59
2.93
3.92
1.1
1.4
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
21
82
2.61
3.91
1.1
1.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
170
1280
1.43
3.88
5.2
4.0
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
18
66
2.77
3.78
1.5
1.3
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
6
5
12.09
3.77
2.2
1.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
17
61
2.83
3.71
4.6
3.4
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
10
25
4.04
3.71
2.0
1.8
ug/l
70.5
95.6
—
10
25
(3042733) HLA Ab [Presence] in Serum
10
25
4.04
3.71
2.0
2.8
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
32
158
2.07
3.56
9.5
9.1
mmol/l
1.1
1.3
1.47
25
139
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
34
172
2.03
3.55
1.6
2.5
g/l
1.5
0.8
0.35
26
148
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
57
342
1.73
3.53
2.0
1.7
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
9
17
5.35
3.52
1.0
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
9
17
5.35
3.52
1.0
1.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
17
63
2.74
3.51
1.2
1.3
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
6
6
10.07
3.50
1.2
1.2
pmol/l
6.6
10.0
—
6
6
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
510
4624
1.38
3.49
28.7
14.0
ml/min/173m2
82.8
79.3
1.83
447
3730
(3035880) pH of Pleural fluid
12
36
3.37
3.49
1.3
1.1
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
39
210
1.91
3.42
1.6
2.2
g/l
3.3
3.7
0.82
20
145
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
39
210
1.91
3.42
1.6
2.2
g/l
7.0
7.4
0.43
20
150
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
39
210
1.91
3.42
1.6
2.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
47
269
1.80
3.42
19.2
12.0
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
9
18
5.05
3.38
1.1
1.1
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
7
10
7.06
3.37
2.9
2.2
umol/l
19.7
15.7
—
7
10
(3026389) Candida sp identified in Specimen by Organism specific culture
17
65
2.66
3.32
1.3
1.3
—
—
—
0
0
(4062490)
16
60
2.71
3.24
1.4
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
19
78
2.48
3.24
1.1
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
22
97
2.31
3.22
2.2
1.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
12
38
3.20
3.22
2.4
1.7
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
36
193
1.91
3.21
1.7
2.2
g/l
3.4
3.1
0.43
20
149
(3010015) Selenium [Moles/volume] in Serum or Plasma
8
15
5.38
3.20
2.1
2.5
umol/l
1.1
1.1
—
8
15
(3052851) Hemolysis interference index of Serum or Plasma
33
172
1.96
3.19
3.4
3.4
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
72
472
1.59
3.19
5.7
3.9
ng/l
233.3
239.5
0.05
66
437
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
71
464
1.59
3.19
3.1
2.6
ug/l
6.0
6.8
0.25
60
399
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
17
67
2.58
3.14
2.5
2.6
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
37
202
1.88
3.13
2.0
2.9
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
9
245
0.36
3.11
1.2
1.4
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
11
34
3.27
3.07
2.7
2.5
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
16
62
2.62
3.06
1.4
1.2
e6/l
85592.8
52518.2
0.22
11
39
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
6
8
7.55
3.06
1.2
1.0
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
43
249
1.77
3.03
2.7
1.7
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
7
12
5.88
3.02
1.7
1.4
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
7
12
5.88
3.02
2.1
2.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
79
536
1.53
3.02
1.4
1.3
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
14
51
2.78
3.00
3.1
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
14
51
2.78
3.00
3.1
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
14
51
2.78
3.00
3.1
1.6
—
—
—
0
0
(3011648) Oxygen content in Venous blood
14
51
2.78
3.00
22.7
12.5
%
10.2
11.1
0.38
14
51
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
5
5
10.06
2.98
1.0
1.4
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
11
35
3.18
2.94
1.0
1.0
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
13
46
2.86
2.93
1.2
1.2
u/ml
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
8
17
4.75
2.92
4.5
6.5
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
8
17
4.75
2.92
4.5
6.5
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
30
3.37
2.91
1.1
1.1
—
—
—
0
0
(3019225) pH of Specimen
73
492
1.54
2.88
6.9
4.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
503
4604
1.33
2.87
6.4
5.9
mmol/mol
39.5
40.0
0.46
468
4252
(3044242) Glucose [Moles/volume] in Arterial blood
12
41
2.96
2.87
1.2
3.0
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
8
18
4.48
2.80
5.8
10.1
—
—
—
0
0
(3004451) EKG impression Narrative
10
31
3.26
2.78
1.3
1.3
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
5
6
8.38
2.75
2.0
1.3
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
7
14
5.04
2.73
1.9
2.1
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
6
10
6.04
2.70
3.0
5.6
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
9
24
3.78
2.68
1.8
2.2
umol/l
57.7
47.4
—
9
18
(3024471) HLA-A [Type]
9
24
3.78
2.68
1.1
1.0
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
73
502
1.51
2.64
3.7
2.4
u/l
46.6
32.2
0.67
67
419
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
9
25
3.63
2.58
3.1
1.1
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
162
1290
1.33
2.55
4.2
3.0
umol/l
2220.3
9085.0
2.18
145
1097
(40761539) Cells [Type] in Urine sediment by Light microscopy
6
11
5.49
2.55
1.0
1.2
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
22
108
2.07
2.54
2.9
1.9
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
10
33
3.06
2.53
1.4
1.3
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
9
26
3.49
2.49
19.4
17.3
nmol/l
1249.2
1612.2
—
9
26
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
9
26
3.49
2.49
17.1
11.7
nmol/l
880.7
929.5
—
9
26
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
17
349
0.47
2.48
1.2
1.6
—
—
—
0
0
(1002224) Polysomnography panel
6
177
0.33
2.42
1.2
1.1
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
10
34
2.97
2.42
2.6
2.4
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
10
34
2.97
2.42
1.7
3.4
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
6
12
5.03
2.40
2.2
2.1
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
9
27
3.36
2.40
1.1
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
20
97
2.09
2.39
1.4
1.7
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
5
8
6.28
2.37
1.0
1.3
u/ml
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
5
8
6.28
2.37
1.4
1.4
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
12
46
2.64
2.37
1.8
1.5
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
21
105
2.03
2.33
16.7
7.0
%
60.8
63.9
0.27
21
105
(3008757) Leukocyte morphology finding [Identifier] in Blood
17
78
2.21
2.32
2.6
4.2
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
13
53
2.48
2.29
1.2
1.1
—
—
—
0
0
(4281824)
12
47
2.58
2.28
1.7
1.0
—
—
—
0
0
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
13
4.65
2.27
7.5
9.8
—
—
—
0
0
(3024932) HLA-DR beta [Type]
8
23
3.51
2.27
1.3
1.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
8
23
3.51
2.27
1.0
1.0
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
29
164
1.80
2.26
5.9
5.3
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
20
374
0.52
2.23
1.3
1.3
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
13
54
2.43
2.21
1.2
1.1
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
12
48
2.53
2.19
4.3
2.9
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
15
67
2.27
2.19
1.4
1.1
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
8
24
3.36
2.18
1.1
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
8
24
3.36
2.18
1.1
1.3
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
28
159
1.79
2.16
1.8
2.1
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
7
19
3.71
2.15
1.7
2.6
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
9
30
3.03
2.15
1.9
1.5
u/field
1.3
3.7
—
9
20
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
31
182
1.74
2.15
1.4
1.4
g/l
0.2
0.2
0.32
31
176
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
16
75
2.16
2.10
1.7
2.5
u/ml
3431.3
59.0
0.47
16
69
(3024869) Neuronal Ab [Presence] in Serum
5
10
5.03
2.07
1.4
1.1
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
7
20
3.52
2.06
3.4
2.8
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
231
1976
1.25
2.05
2.3
2.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
13
57
2.30
1.98
1.2
1.1
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
7
21
3.36
1.97
1.9
1.7
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
7
21
3.36
1.97
1.3
1.2
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
7
21
3.36
1.97
1.9
1.7
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
527
4944
1.27
1.96
30.4
16.8
%
37.2
39.2
5.53
288
3582
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
87
1132
0.74
1.95
1.6
1.7
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
6
16
3.77
1.94
1.2
1.0
miu/ml
1859.3
1197.4
—
6
16
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
6
16
3.77
1.94
6.2
1.3
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
11
45
2.47
1.93
1.0
1.0
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32
196
1.66
1.93
1.7
2.2
g/l
10.1
10.3
0.05
22
165
(3024980) IgG subclass 4 [Mass/volume] in Serum
18
92
1.98
1.91
1.7
1.7
g/l
0.8
0.8
0.09
13
74
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
14
65
2.18
1.89
2.1
1.6
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
7
22
3.20
1.88
1.9
1.7
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
30
183
1.67
1.85
1.6
1.2
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
623
5988
1.37
1.84
48.3
22.0
e9/l
263.5
249.8
3.84
612
5801
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
10
40
2.52
1.84
2.3
4.1
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
6
17
3.55
1.84
6.7
10.1
—
—
—
0
0
(3024731) MCV [Entitic volume]
623
5989
1.37
1.83
48.1
21.9
fl
91.2
90.3
3.69
616
5892
(3035941) MCH [Entitic mass]
623
5991
1.36
1.81
48.1
21.9
pg
30.2
30.1
0.56
616
5893
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
7
23
3.06
1.80
11.0
6.3
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
623
5992
1.36
1.80
48.3
22.0
e12/l
4.1
4.5
34.00
609
5787
(3014765) Yersinia sp identified in Stool by Organism specific culture
30
185
1.65
1.78
1.6
1.2
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
31
193
1.63
1.77
1.4
1.4
g/l
1.1
1.2
0.60
31
185
(3000963) Hemoglobin [Mass/volume] in Blood
623
5994
1.36
1.77
49.0
22.1
g/l
123.4
133.3
42.27
616
5894
(3010813) Leukocytes [#/volume] in Blood
623
5995
1.36
1.76
48.5
22.0
e9/l
7.3
6.9
3.07
609
5786
(3028679) Herpes simplex virus Ab [Presence] in Serum
6
18
3.35
1.75
1.0
1.3
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
8
30
2.69
1.73
1.0
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
30
187
1.63
1.72
1.6
1.2
—
—
—
0
0
(3014891) Appearance of Pleural fluid
5
13
3.87
1.72
2.2
1.3
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
5
13
3.87
1.72
1.0
1.1
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
12
55
2.20
1.68
1.5
1.5
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
22
128
1.74
1.62
1.3
1.6
iu/l
3.7
6.6
—
7
38
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
10
43
2.34
1.61
1.1
1.0
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
51
364
1.43
1.60
1.5
1.4
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
6
20
3.02
1.58
1.3
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
6
20
3.02
1.58
1.3
1.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
30
192
1.59
1.56
1.6
1.6
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
42
291
1.47
1.54
3.1
2.6
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
5
15
3.35
1.52
1.4
1.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
13
65
2.02
1.49
4.4
3.1
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
7
28
2.51
1.45
4.1
1.6
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
7
28
2.51
1.45
4.1
1.6
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
7
28
2.51
1.45
4.1
1.6
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
7
28
2.51
1.45
4.1
1.6
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
32
213
1.53
1.43
1.3
2.1
u/l
39.9
39.3
0.05
27
183
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
121
1003
1.25
1.40
4.1
3.3
e6/l
1.6
1.0
0.67
82
599
(3045788) Cell count panel - Pleural fluid
11
53
2.09
1.39
1.4
1.3
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
12
60
2.02
1.38
4.0
3.4
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
6
23
2.62
1.37
1.2
1.1
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
5
17
2.95
1.36
2.4
2.5
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
5
17
2.95
1.36
1.4
1.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
5
17
2.95
1.36
1.2
1.2
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
0
37
0.00
1.34
0.0
1.8
—
7.3
—
0
22
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
10
47
2.14
1.34
1.2
1.5
—
22.3
—
0
7
(3017446) Testosterone [Moles/volume] in Serum or Plasma
47
344
1.39
1.32
2.1
2.2
nmol/l
12.7
12.5
0.04
37
298
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
513
4873
1.20
1.32
4.7
4.5
mmol/l
5.9
5.9
0.38
466
4390
(40768441) Liver Pathology biopsy report
9
43
2.11
1.30
1.1
1.4
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
46
617
0.73
1.29
4.0
4.3
%
36.9
32.2
1.38
34
406
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
12
62
1.95
1.28
2.7
4.3
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
35
2.30
1.27
1.1
1.1
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
5
19
2.64
1.22
1.2
1.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
45
599
0.73
1.21
1.7
1.7
—
—
—
0
0
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
6
26
2.32
1.19
2.5
1.8
ng/l
160.1
142.1
—
6
21
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
11
57
1.94
1.17
1.3
1.3
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
186
1639
1.18
1.17
3.9
3.4
mmol/l
6.7
7.4
0.89
152
1364
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
5
20
2.51
1.15
2.6
1.6
nmol/l
1.8
12.7
—
5
14
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
10
51
1.97
1.11
7.5
3.3
u/ml
18.2
86.2
—
5
14
(3045142) Bone marrow Pathology biopsy report
13
73
1.80
1.11
1.5
1.3
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
5
21
2.39
1.09
1.2
1.1
—
—
—
0
0
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
5
21
2.39
1.09
1.0
1.3
u/ml
0.7
3.8
—
5
16
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
21
2.39
1.09
1.2
1.1
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
5
21
2.39
1.09
1.2
1.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
40
297
1.37
1.07
1.5
1.3
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
9
46
1.97
1.04
1.7
2.9
—
—
—
0
0
(3024263) Appearance of Synovial fluid
5
22
2.28
1.03
1.8
1.4
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
5
22
2.28
1.03
1.0
1.6
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
5
22
2.28
1.03
3.2
3.3
umol/l
20.8
37.1
—
5
15
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
19
122
1.57
1.03
1.7
1.3
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
369
3455
1.14
1.01
3.0
3.1
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
5
23
2.18
0.98
1.8
1.4
—
—
—
0
0
(3045462) Protein/Creatinine [Ratio] in Urine
7
36
1.95
0.97
5.0
9.9
g/mol
29.3
1498.9
—
7
31
(3008898) HLA-B27 [Presence]
13
210
0.61
0.96
1.2
1.1
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
27
2.23
0.93
1.0
1.1
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
6
27
2.23
0.93
2.2
2.4
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
15
94
1.61
0.91
1.1
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
12
71
1.70
0.89
1.2
1.1
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
6
30
2.01
0.87
1.2
1.5
g/l
0.7
1.0
—
6
30
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
24
170
1.43
0.86
1.8
2.2
g/l
31.6
37.9
1.84
18
140
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
23
162
1.43
0.85
1.2
1.3
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
8
45
1.79
0.84
1.4
2.2
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
8
45
1.79
0.84
1.4
2.2
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
10
58
1.73
0.80
2.0
1.3
nmol/l
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
159
1427
1.15
0.79
3.8
5.0
ug/l
3.0
2.7
0.11
136
1254
(4211845)
0
24
0.00
0.79
0.0
3.4
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
24
0.00
0.79
0.0
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
175
1585
1.14
0.77
3.1
2.9
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
7
38
1.85
0.73
1.1
1.0
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
34
264
1.30
0.73
2.1
2.8
u/ml
40.7
69.0
0.61
34
256
(3027231) Wheat IgE Ab [Units/volume] in Serum
5
25
2.01
0.73
1.0
1.2
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
7
39
1.80
0.72
4.4
2.9
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
11
68
1.63
0.72
1.4
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
24
177
1.37
0.71
2.8
1.8
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
16
109
1.48
0.71
1.2
1.3
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
97
847
1.17
0.71
1.2
1.3
iu/ml
28.7
32.9
0.15
32
254
(3005570) Glucose [Moles/volume] in Urine
9
58
1.56
0.70
1.8
2.1
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
5
27
1.86
0.68
1.2
1.6
nmol/l
1.2
0.8
—
5
20
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
5
28
1.79
0.66
1.2
1.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
21
155
1.37
0.63
1.6
1.3
—
—
—
0
0
(3017704) Immunofixation for Urine
5
30
1.67
0.61
1.0
1.3
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
8
51
1.58
0.60
2.3
3.4
u/ml
19.9
50.6
—
8
51
(44806420)
0
20
0.00
0.60
0.0
2.7
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
20
0.00
0.60
0.0
1.4
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
21
0.00
0.60
0.0
1.2
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
21
0.00
0.60
0.0
3.8
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
18
131
1.38
0.59
3.0
2.6
ug/min
55.8
62.1
—
10
78
(3032773) Endomysium IgG Ab [Titer] in Serum
11
72
1.54
0.59
1.0
1.1
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
20
149
1.35
0.58
1.6
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
20
149
1.35
0.58
1.6
1.3
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
8
54
1.49
0.57
1.0
1.1
—
—
—
0
0
(3002256) Pathology report gross observation
73
636
1.17
0.57
1.2
1.3
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
6
38
1.58
0.54
1.7
1.8
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
9
62
1.46
0.53
1.2
1.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
9
62
1.46
0.53
1.2
1.4
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
9
62
1.46
0.53
1.8
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
9
62
1.46
0.53
1.2
1.5
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
10
66
1.52
0.52
2.0
1.3
nmol/l
0.7
0.6
—
10
59
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
16
117
1.38
0.52
1.1
1.3
—
—
—
0
0
(4034850)
12
169
0.71
0.52
22.1
9.7
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
9
63
1.43
0.52
1.2
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
9
63
1.43
0.52
1.2
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
9
63
1.43
0.52
1.2
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
6
96
0.62
0.52
2.5
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
6
96
0.62
0.52
2.5
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
6
100
0.60
0.52
2.7
1.5
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
6
40
1.50
0.51
1.2
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
6
41
1.47
0.50
1.2
1.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
12
84
1.44
0.49
1.2
1.4
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
7
45
1.56
0.49
2.1
1.4
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
477
4637
1.09
0.48
4.3
3.9
mmol/l
1.2
1.3
0.49
425
4194
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
29
354
0.81
0.48
2.0
2.0
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
12
85
1.42
0.47
3.2
2.5
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
8
119
0.67
0.46
1.0
1.3
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
18
139
1.30
0.44
1.3
1.2
u/ml
3.8
1.1
0.69
11
94
(36660697) Celiac disease serology panel - Serum
58
509
1.15
0.44
1.2
1.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
8
56
1.43
0.42
1.3
1.9
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
14
105
1.34
0.41
1.6
1.7
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
3.3
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
18
0.00
0.40
0.0
1.5
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
74
817
0.89
0.38
2.2
3.0
ug/l
1.5
0.8
0.91
47
538
(3003888) Timothy IgE Ab [Units/volume] in Serum
18
143
1.27
0.37
1.3
1.2
u/ml
1.8
6.3
2.15
12
101
(3001019) Free T4 and TSH panel - Serum or Plasma
14
178
0.78
0.34
1.5
1.8
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
21
172
1.23
0.34
1.2
1.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
88
808
1.10
0.34
1.2
1.3
u/ml
1.3
8.5
4.06
38
294
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
6
44
1.37
0.34
1.5
1.2
—
105.7
—
0
7
(40768795) Lymph node Pathology biopsy report
6
44
1.37
0.34
1.0
1.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
14
109
1.29
0.33
2.0
1.3
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
6
46
1.31
0.33
1.3
1.4
—
418.6
—
0
7
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
6
47
1.28
0.32
1.3
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
41
361
1.14
0.32
1.3
1.2
iu/ml
37.8
126.0
2.92
12
129
(3004616) Nuclear Ab [Presence] in Serum
7
55
1.28
0.30
1.0
1.2
—
—
—
0
0
(4268621)
7
56
1.25
0.29
2.0
2.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
16
130
1.24
0.29
1.3
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
44
490
0.89
0.28
1.7
1.7
—
—
—
0
0
(3000492) Spirometry study
49
442
1.12
0.28
1.5
1.5
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
24
279
0.86
0.27
1.8
1.9
—
—
—
0
0
(4010399)
40
357
1.13
0.27
1.6
1.5
—
—
—
0
0
(4306422)
8
66
1.21
0.27
1.0
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
55
501
1.11
0.26
1.5
1.7
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
124
1310
0.94
0.26
1.7
1.7
mmol/l
1.3
1.3
0.26
101
1102
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
5
73
0.68
0.26
1.0
1.1
—
6.5
—
0
14
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
20
169
1.19
0.26
1.7
1.5
iu/ml
0.0
0.1
—
6
38
(3016879) Cocaine [Presence] in Urine
25
216
1.16
0.26
2.8
1.7
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
10
127
0.78
0.25
3.6
2.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
10
126
0.79
0.24
1.3
1.3
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
18
152
1.19
0.24
3.6
2.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
10
125
0.80
0.23
2.2
1.5
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
5
39
1.28
0.23
1.8
1.4
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
18
153
1.18
0.22
1.4
1.3
u/ml
6.8
2.1
0.45
11
92
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
18
153
1.18
0.22
2.1
1.7
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
26
294
0.88
0.22
6.5
4.1
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
1.7
—
0
6
(40758292) HTLV I+II Ab panel - Serum
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
38.7
—
0
5
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
12
98
1.23
0.21
1.5
1.2
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
2.0
—
2.4
—
0
5
(4024509)
6
53
1.13
0.18
1.2
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
21
185
1.14
0.18
1.4
1.6
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
5
69
0.72
0.17
1.2
1.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
6
77
0.78
0.15
1.0
1.4
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
6
80
0.75
0.15
1.2
1.4
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
10
84
1.19
0.14
1.9
1.9
pmol/l
234.2
234.7
—
10
79
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
490
4851
1.03
0.13
4.6
4.3
mmol/l
4.3
4.6
4.25
439
4439
(3000764) Benzodiazepines [Presence] in Urine
25
228
1.10
0.13
2.8
1.7
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
16
180
0.89
0.13
2.1
2.0
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
20
221
0.90
0.13
1.7
1.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
25
229
1.10
0.12
2.8
1.7
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
25
229
1.10
0.12
2.8
1.7
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
111
1147
0.96
0.12
3.6
4.4
%
21.7
21.2
0.12
56
559
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
12
105
1.15
0.11
1.0
1.2
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
16
144
1.11
0.10
1.9
1.4
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
12
106
1.13
0.10
1.1
1.1
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
156
1529
1.03
0.08
4.5
3.9
mg/mmol
19.4
20.9
0.04
105
971
(21494434) Karyotype in Bone marrow
6
58
1.03
0.08
1.3
1.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
21
226
0.93
0.08
1.4
1.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
5
63
0.79
0.08
1.2
1.0
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
7
67
1.05
0.08
1.0
1.3
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
6
71
0.84
0.07
1.3
1.5
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
31
327
0.95
0.07
1.1
1.0
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
20
186
1.08
0.07
1.5
1.2
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
16
147
1.09
0.07
1.5
1.3
miu/ml
246.8
268.3
—
5
63
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
493
4959
0.98
0.07
4.8
4.8
mmol/l
2.5
2.7
4.80
446
4513
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
7
84
0.83
0.07
1.3
1.5
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
148
1454
1.02
0.07
3.3
3.2
mg/l
823.4
276.9
0.53
102
944
(3022621) pH of Urine by Test strip
37
354
1.05
0.06
4.4
3.3
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
9
100
0.90
0.06
2.3
1.7
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
10
111
0.90
0.06
2.0
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
10
111
0.90
0.06
2.0
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
10
111
0.90
0.06
2.0
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
10
111
0.90
0.06
2.0
1.5
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
479
4811
0.99
0.04
4.5
4.3
mmol/l
1.5
1.5
0.14
432
4378
(3027944) Amphetamines [Presence] in Urine
24
229
1.05
0.04
2.9
1.7
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
21
220
0.95
0.03
2.4
1.9
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
60
589
1.02
0.03
2.2
2.2
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
20
202
0.99
0.00
3.4
3.0
u/ml
272.5
13541.5
0.53
15
174
(3013139) Helicobacter pylori Ag [Presence] in Stool
32
318
1.01
0.00
1.4
1.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
37
372
0.99
0.00
4.8
2.8
e9/l
4.3
4.1
0.10
29
295
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
11
109
1.01
0.00
1.4
1.6
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
54
542
1.00
0.00
2.1
2.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
70
701
1.00
0.00
1.5
1.4
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
7
73
0.96
0.00
1.0
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
12
120
1.00
0.00
1.8
1.4
—
—
—
0
0
(3006598) pH of Arterial cord blood
5
49
1.02
0.00
1.0
1.0
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044416) Complement C4 [Mass/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
0.1
—
0
5
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003721) Smooth muscle Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
6
60
1.00
0.00
1.0
1.2
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
8
81
0.99
0.00
1.0
1.1
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
6
0.00
0.00
0.0
2.8
—
—
—
0
0
(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
5
0.00
0.00
0.0
3.6
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44806071)
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint E4_MALNUTRITION and mortality.

Females

Parameter HR [95% CI] p-value
E4_MALNUTRITION 3.526 [2.72, 4.58] < 0.001
Birth year 0.994 [0.99, 1.0] 0.157

During the follow-up period (1.1.1998 — 31.12.2019), 1285 out of 3662 females with E4_MALNUTRITION died.

Males

Parameter HR [95% CI] p-value
E4_MALNUTRITION 4.659 [3.32, 6.54] < 0.001
Birth year 0.987 [0.98, 1.0] 0.006

During the follow-up period (1.1.1998 — 31.12.2019), 1087 out of 2742 males with E4_MALNUTRITION died.

Mortality risk

Mortality risk for people of age

years, who have E4_MALNUTRITION.

N-year risk Females Males
1 0.257% 1.008%
5 1.853% 5.19%
10 4.843% 12.782%
15 8.936% 22.768%
20 15.271% 36.475%

Relationships between endpoints

↥

Index endpoint: E4_MALNUTRITION – Malnutrition

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data